Z-Ala-Arg-Arg-AMC is a fluorogenic substrate designed for proteases recognizing basic residues. The AMC moiety produces strong fluorescence upon cleavage. Protective groups enhance assay stability. Researchers use it in kinetic and specificity evaluations.
CAT No: P6303
CAS No:90468-18-1
Synonyms/Alias:Z-Ala-Arg-Arg-AMC;90468-18-1;Z-Ala-Arg-Arg-AMC hydrochloride salt;benzyl N-[(2S)-1-[[(2S)-5-(diaminomethylideneamino)-1-[[(2S)-5-(diaminomethylideneamino)-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]carbamate;Proteasome Substrate VI, Fluorogenic;Z-Ala-Arg-Arg-MCA;Z-Ala-Arg-Arg-7-Amino-4-Methylcoumarin;DTXSID801112888;Proteasome substrate vi,fluorogenic;DA-79062;FA110489;HY-134961;CS-0167607;Proteasome Substrate VI, Fluorogenic - CAS 90468-18-1;benzyl (S)-1-((S)-5-guanidino-1-((S)-5-guanidino-1-(4-methyl-2-oxo-2H-chromen-7-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopropan-2-ylcarbamate;N-[(Phenylmethoxy)carbonyl]-L-alanyl-L-arginyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-argininamide;
1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More